Thyroid dysfunction and immune checkpoint inhibitor outcomes.

被引：0
|
作者：
von Itzstein, Mitchell S.
Lu, Rong
Ali, Sadia
Xie, Donglu
Cai, Jennifer
Xie, Yang
Gerber, David E.
机构：
[1] UT Southwestern, Dallas, TX USA
[2] UT Southwestern Med Ctr, Dallas, TX USA
[3] Univ Texas Southwestern Med Ctr Dallas, Simmons Canc Ctr, Dallas, TX 75390 USA
[4] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15103
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Immune checkpoint inhibitor-related thyroid dysfunction
    Illouz, Frederic
    Briet, Claire
    Rodien, Patrice
    ANNALES D ENDOCRINOLOGIE, 2023, 84 (03) : 346 - 350
  • [2] Thyroid dysfunction caused by immune checkpoint inhibitors improves cancer outcomes
    Garcia-Goni, Marta
    Gutierrez, Beatriz Vazquez
    Sanmamed, Miguel F.
    Martin-Algarra, Salvador
    Luis Perez-Gracia, Jose
    Olmedo, Maria
    Chumbiauca, Estefania
    Martin-Calvo, Nerea
    Galofre, Juan C.
    ENDOCRINE-RELATED CANCER, 2024, 31 (10)
  • [3] Clinical Characters and Influence Factors of Immune Checkpoint Inhibitor-related Thyroid Dysfunction
    Zhang, Qin
    Jiao, Xiaojuan
    Lai, Xiaoyang
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 108 (11): : 2916 - 2923
  • [4] Immune checkpoint inhibitor induced thyroid dysfunction is a frequent event post-treatment in NSCLC
    Zhou, Nanruoyi
    Velez, Maria A.
    Bachrach, Benjamin
    Gukasyan, Jaklin
    Fares, Charlene M.
    Cummings, Amy L.
    Lind-Lebuffe, Jackson P.
    Akingbemi, Wisdom O.
    Li, Debory Y.
    Brodrick, Paige M.
    Yessuf, Nawal M.
    Rettinger, Sarah
    Grogan, Tristan
    Rochigneux, Philippe
    Goldman, Jonathan W.
    Garon, Edward B.
    Lisberg, Aaron
    LUNG CANCER, 2021, 161 : 34 - 41
  • [5] Immune Checkpoint Inhibitor-induced Thyroid Dysfunction Is Associated with Higher Body Mass Index
    Pollack, Rena
    Ashash, Amit
    Cahn, Avivit
    Rottenberg, Yakir
    Stern, Hagay
    Dresner-Pollak, Rivka
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (10): : 1 - 8
  • [6] THYROID DYSFUNCTION IN CHILDREN RECEIVING IMMUNE CHECKPOINT INHIBITORS
    Metzinger, Emily
    Boyd, Jennifer
    Broussard, Julia
    Klockau, Christopher
    HORMONE RESEARCH IN PAEDIATRICS, 2024, 97 : 132 - 133
  • [7] An Evanishing Thyroid During Immune Checkpoint Inhibitor Therapy
    Cuzzocrea, Marco
    Paone, Gaetano
    Ceriani, Luca
    Giovanella, Luca
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (03) : 253 - 254
  • [8] Thyroid disorders during immune checkpoint inhibitor therapy
    Theiler-Schwetz, Verena
    Trummer, Christian
    Richtig, Erika
    Richtig, Georg
    Pilz, Stefan
    AUSTRIAN JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, 2020, 13 (03): : 115 - 118
  • [9] Endocrine dysfunction following immune checkpoint inhibitor therapy
    Konda, Bhavana
    Nabhan, Fadi
    Shah, Manisha H.
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2017, 24 (05) : 337 - 347
  • [10] Immune checkpoint inhibitor (ICI) treatment in advanced melanoma (aMel) patients (pts) with renal or hepatic dysfunction (dysf): Real-world patient characteristics and outcomes.
    Spillane, Susan
    Abernethy, Amy Pickar
    Brown, Nicholas R.
    Freedman, Andrew N.
    Lenis, David
    Maignan, Kathleen
    Mariotto, Angela
    Miksad, Rebecca A.
    Torres, Aracelis Z.
    Sharon, Elad
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345